| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |